Value-based pricing of a COVID-19 vaccine
Afschin Gandjour
doi: https://doi.org/10.1101/2021.03.06.21253035
Afschin Gandjour
Frankfurt School of Finance & Management, Frankfurt, Germany
MD, PhD, MAData Availability
All data are contained within the manuscript.
Posted March 08, 2021.
Value-based pricing of a COVID-19 vaccine
Afschin Gandjour
medRxiv 2021.03.06.21253035; doi: https://doi.org/10.1101/2021.03.06.21253035
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (631)
- Anesthesia (167)
- Cardiovascular Medicine (2395)
- Dermatology (207)
- Emergency Medicine (380)
- Epidemiology (11788)
- Forensic Medicine (10)
- Gastroenterology (704)
- Genetic and Genomic Medicine (3761)
- Geriatric Medicine (350)
- Health Economics (636)
- Health Informatics (2406)
- Health Policy (936)
- Hematology (342)
- HIV/AIDS (784)
- Medical Education (366)
- Medical Ethics (105)
- Nephrology (401)
- Neurology (3521)
- Nursing (199)
- Nutrition (528)
- Oncology (1828)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (66)
- Pathology (447)
- Pediatrics (1035)
- Primary Care Research (424)
- Public and Global Health (6168)
- Radiology and Imaging (1286)
- Respiratory Medicine (831)
- Rheumatology (379)
- Sports Medicine (324)
- Surgery (403)
- Toxicology (50)
- Transplantation (172)
- Urology (147)